DK1222192T3 - Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor - Google Patents

Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor

Info

Publication number
DK1222192T3
DK1222192T3 DK00966144T DK00966144T DK1222192T3 DK 1222192 T3 DK1222192 T3 DK 1222192T3 DK 00966144 T DK00966144 T DK 00966144T DK 00966144 T DK00966144 T DK 00966144T DK 1222192 T3 DK1222192 T3 DK 1222192T3
Authority
DK
Denmark
Prior art keywords
hexahydrofuro
ylsulfonyl
benzodioxol
furan
isobutyl
Prior art date
Application number
DK00966144T
Other languages
English (en)
Inventor
Michael Eissenstat
John W Erickson
Piet Tom Bert Paul Wigerinck
Guangyang Wang
Original Assignee
Tibotec Pharm Ltd
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd, Us Gov Health & Human Serv filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of DK1222192T3 publication Critical patent/DK1222192T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK00966144T 1999-10-06 2000-10-06 Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor DK1222192T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15785099P 1999-10-06 1999-10-06
PCT/EP2000/009917 WO2001025240A1 (en) 1999-10-06 2000-10-06 HEXAHYDROFURO'2,3-B!FURAN-3-YL-N- {3'(1,3-BENZODIOXOL -5- YLSULFONYL) (ISOBUTYL) AMINO! -1-BENZYL-2-HYDROXYPROPYL} CARBAMATE AS RETROVIRAL PROTEASE INHIBITOR

Publications (1)

Publication Number Publication Date
DK1222192T3 true DK1222192T3 (da) 2008-10-20

Family

ID=22565540

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00966144T DK1222192T3 (da) 1999-10-06 2000-10-06 Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor

Country Status (25)

Country Link
US (2) US6649651B1 (da)
EP (1) EP1222192B8 (da)
JP (1) JP4951179B2 (da)
KR (1) KR100792391B1 (da)
CN (1) CN1191256C (da)
AP (1) AP1459A (da)
AT (1) ATE398623T1 (da)
AU (1) AU781656B2 (da)
BR (1) BR0014602A (da)
CA (1) CA2386850C (da)
CZ (1) CZ300031B6 (da)
DE (1) DE60039244D1 (da)
DK (1) DK1222192T3 (da)
ES (1) ES2307533T3 (da)
HU (1) HU228938B1 (da)
IL (2) IL149005A0 (da)
MX (1) MXPA02003607A (da)
NO (1) NO327996B1 (da)
NZ (1) NZ518580A (da)
OA (1) OA12053A (da)
PL (1) PL204924B1 (da)
RU (1) RU2247123C2 (da)
SK (1) SK287153B6 (da)
WO (1) WO2001025240A1 (da)
ZA (1) ZA200202655B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1222192B8 (en) * 1999-10-06 2008-10-01 Tibotec Pharmaceuticals Ltd. Hexahydrofuro¬2,3-b furan-3-yl-n- 3-¬(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino -1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor
AR035819A1 (es) * 2001-04-09 2004-07-14 Tibotec Pharm Ltd 2-(amino sustituido)-benzoxazol sulfonamidas, inhibidoras de la proteasa del hiv, composiciones farmaceuticas que comprenden dichos compuestos, metodo in vitro para inhibir la replicacion retroviral y uso de dichos compuestos en la fabricacion de medicamentos
EA010883B1 (ru) * 2001-09-10 2008-12-30 Тиботек Фармасьютикалз Лтд. Способ получения гексагидрофуро[2,3-в]фуран-3-ола
AU2003202914A1 (en) * 2002-01-07 2003-07-24 Sequoia Pharmaceuticals Broad spectrum inhibitors
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) * 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
KR101019648B1 (ko) 2002-05-17 2011-03-07 티보텍 파마슈티컬즈 광범위 스펙트럼의 치환된 벤즈이속사졸 설폰아미드ｈｉｖ 프로테아제 저해제
KR101327772B1 (ko) * 2002-08-02 2013-11-11 얀센 알 앤드 디 아일랜드 광범위 2-아미노-벤조티아졸 설폰아미드 ｈｉｖ 프로테아제 저해제
WO2004060895A1 (ja) 2002-12-27 2004-07-22 Sumitomo Chemical Company, Limited ヘキサヒドロフロフラノール誘導体の製造方法、その中間体及びその製造方法
EP1732891A4 (en) * 2004-03-11 2009-05-06 Sequoia Pharmaceuticals Inc RESISTANT PREVENTIVE INHIBITORS FOR RETROVIRAL PROTEASES
TWI383975B (zh) 2004-03-31 2013-02-01 悌柏泰克醫藥有限公司 製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法
KR100698291B1 (ko) * 2004-12-29 2007-03-22 엘지전자 주식회사 조명계
RU2421459C2 (ru) 2005-02-25 2011-06-20 Тиботек Фармасьютикалз Лтд. Синтез предшественника ингибитора протеазы
FR2888849B1 (fr) * 2005-07-19 2007-10-05 Pierre Fabre Medicament Sa Procede de preparation de la 4b-amino-4'-demethyl-4-desoxypodophyllotoxine
SG183007A1 (en) 2006-07-07 2012-08-30 Gilead Sciences Inc Modulators of pharmacokinetic properties of therapeutics
US20080070910A1 (en) * 2006-07-24 2008-03-20 Desai Manoj C Therapeutic compounds and methods
MX2009004957A (es) 2006-11-09 2009-05-19 Tibotec Pharm Ltd Metodos para la preparacion de hexahidrofuro[2,3-b]furan-3-ol.
US9808527B2 (en) 2006-11-21 2017-11-07 Purdue Research Foundation Methods and compositions for treating HIV infections
PL3150586T3 (pl) 2007-02-23 2020-06-01 Gilead Sciences, Inc. Modulatory farmakokinetycznych właściwości środków terapeutycznych
US7981929B2 (en) * 2007-03-16 2011-07-19 Sequoia Pharmaceuticals, Inc. Benzofuran derived HIV protease inhibitors
EP2170851B1 (en) 2007-07-06 2013-09-04 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
PT2231628E (pt) 2008-01-04 2015-12-29 Gilead Sciences Inc Inibidores de citocromo p450
WO2009091941A1 (en) 2008-01-17 2009-07-23 Purdue Research Foundation Small molecule inhibitors of hiv proteases
US8791135B2 (en) 2008-07-01 2014-07-29 Purdue Research Foundation Nonpeptide HIV-1 protease inhibitors
US8501961B2 (en) * 2008-07-09 2013-08-06 Purdue Research Foundation HIV protease inhibitors and methods for using
UA112155C2 (uk) 2009-12-21 2016-08-10 ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі Розкладаний видалюваний імплантат для безперервного вивільнення активної сполуки
DK2643326T3 (da) 2010-11-23 2017-01-09 Mylan Laboratories Ltd Fremgangsmåde til fremstilling af (3R, 3aS, 6aR)-hexahydrofuro[2,3-b]furan-3-ol
CN104520262A (zh) * 2012-08-09 2015-04-15 住友化学株式会社 六氢呋喃并呋喃醇衍生物的制造方法
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004491A1 (en) * 1992-08-25 1994-03-03 G.D. Searle & Co. N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors
ATE218541T1 (de) * 1992-08-25 2002-06-15 Searle & Co Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
EP0715618B1 (en) 1993-08-24 1998-12-16 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
PT2336134T (pt) 1998-06-23 2016-10-19 The Board Of Trustees Of The Univ Of Illionis Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
GB9815567D0 (en) * 1998-07-18 1998-09-16 Glaxo Group Ltd Antiviral compound
EP1222192B8 (en) * 1999-10-06 2008-10-01 Tibotec Pharmaceuticals Ltd. Hexahydrofuro¬2,3-b furan-3-yl-n- 3-¬(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino -1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor

Also Published As

Publication number Publication date
JP2003511383A (ja) 2003-03-25
PL354351A1 (en) 2004-01-12
US20050261364A1 (en) 2005-11-24
WO2001025240A1 (en) 2001-04-12
AP1459A (en) 2005-08-22
KR20020067503A (ko) 2002-08-22
ATE398623T1 (de) 2008-07-15
IL149005A (en) 2006-12-31
HK1054746A1 (en) 2003-12-12
DE60039244D1 (de) 2008-07-31
CZ20021419A3 (cs) 2002-10-16
ZA200202655B (en) 2003-09-23
EP1222192B8 (en) 2008-10-01
HUP0203130A3 (en) 2005-01-28
PL204924B1 (pl) 2010-02-26
CA2386850C (en) 2010-03-30
CA2386850A1 (en) 2001-04-12
NO20021598D0 (no) 2002-04-04
ES2307533T3 (es) 2008-12-01
JP4951179B2 (ja) 2012-06-13
OA12053A (en) 2006-05-02
EP1222192A1 (en) 2002-07-17
CN1407987A (zh) 2003-04-02
NO327996B1 (no) 2009-11-02
BR0014602A (pt) 2002-06-11
AU781656B2 (en) 2005-06-02
CN1191256C (zh) 2005-03-02
CZ300031B6 (cs) 2009-01-14
MXPA02003607A (es) 2003-07-28
AU7663800A (en) 2001-05-10
KR100792391B1 (ko) 2008-01-08
HUP0203130A2 (hu) 2003-01-28
SK5702002A3 (en) 2003-01-09
SK287153B6 (sk) 2010-01-07
NZ518580A (en) 2004-01-30
RU2247123C2 (ru) 2005-02-27
AP2002002472A0 (en) 2002-06-30
HU228938B1 (hu) 2013-06-28
US6649651B1 (en) 2003-11-18
US7157495B2 (en) 2007-01-02
NO20021598L (no) 2002-05-29
IL149005A0 (en) 2002-11-10
EP1222192B1 (en) 2008-06-18

Similar Documents

Publication Publication Date Title
DK1222192T3 (da) Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor
NO20015477D0 (no) 4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
NO20014412D0 (no) Forbindelser nyttige som anti-inflammatoriske midler
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
NO20041560L (no) 1,6-nafthyridinderivater som antidiabetiske midler
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
DK0933372T3 (da) Sulfonamidderivater som prodrugs for aspartylproteaseinhibitorer
NO20002444D0 (no) 2-fenyl-substituerte imidazotriazinoner som fosfodiesteraseinhibitorer
NO20014483D0 (no) Aminderivater som proteaseinhibitorer
NO20011738D0 (no) Heterocyclylaminometyloksazolidinoner som antibakterielle midler
NO20022557D0 (no) 2,4-diaminopyrimidinforbindelser nyttige som immunosuppreserende midler
NO20013675L (no) 2,3,4,5-tetrahydro-1H-[1,4)benzodiazepin-3-hydroksamsyre som matriks-metalloproteinase-inhibitorer
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO20015078L (no) Sulfonamidderivater som har oksadiazolringer
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
NO20012526L (no) Sammensetninger som innbefatter cefuroksimaksetil
DK1023268T3 (da) Isoquinoliner som urokinaseinhibitorer.
NO20034527L (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
NO20015668D0 (no) Substituerte imidazotiazoler som antidepressive midler
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
NO981846D0 (no) Beskyttelsesbrille, spesielt arbeidsbeskyttelsesbrille
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
NO20013853L (no) Heteroarylamidiner, metylamidiner og guanidiner som proteaseinhibitorer
NO20012965D0 (no) Sulfonyloksazolaminer som terapeutisk aktive forbindelser
DK1075471T3 (da) Idolylderivater som serotonerge midler